Physician profile
Elli Jones
NPI 1750822524
$727.65
in general payments reported to CMS, 2019-2025
16 companies · $264 in 2025
The $264 reported for 2025 was more than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $74.98 · 2023: $364 · 2024: $24.77 · 2025: $264.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $653.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $652.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $208.53 | 2023-2025 | Rexulti, Abilify Maintena, Nuedexta |
| Neurocrine Biosciences, INC. | $150.19 | 2023-2025 | Ingrezza |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $63.12 | 2023 | Caplyta |
| Corium, LLC | $46.40 | 2023 | Azstarys |
| Vanda Pharmaceuticals INC. | $31.77 | 2022 | |
| Neos Therapeutics, LP | $30.01 | 2023 | Adzenys Xr-Odt |
| Abbvie INC. | $25.53 | 2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $25.37 | 2023 | Trintellix |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $24.13 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $23.02 | 2023 | Austedo Xr |
| Janssen Pharmaceuticals, INC | $21.83 | 2023 | Spravato |
| Idorsia Pharmaceuticals US INC | $19.08 | 2022 | |
| Tris Pharma INC | $16.46 | 2025 | Dyanavel Xr |
| Merck Sharp & Dohme LLC | $16.01 | 2023 | Belsomra |
| Noven Therapeutics, LLC | $13.25 | 2023 | Xelstrym |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironshore Pharmaceuticals INC. | $12.95 | 2023 | Jornay Pm |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elli Jones listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.